Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Gemcabene

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gemphire cuts 33% of staff, including CFO, CMO
    Gemphire cuts 33% of staff, including CFO, CMO

    25 Sep 2018

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gemphire-cuts-33-staff-including-cfo-cmo

    Amirah Al Idrus FIERCE BIOTECH
    25 Sep 2018
    Share Share
    In back-to-back trial disasters, Gemphire now says it shuttered a trial
    In back-to-back trial disasters, Gemphire now says it shuttered a trial

    10 Aug 2018

    // John Carroll ENDPTS

    https://endpts.com/in-back-to-back-trial-disasters-gemphire-now-says-it-shuttered-a-trial-after-seeing-patients-fatty-liver-disease-get-worse/

    John Carroll ENDPTS
    10 Aug 2018
    Share Share
    Battered Gemphire shares soar on new triglyceride data, but there’s a lot left
    Battered Gemphire shares soar on new triglyceride data, but there’s a lot left

    30 Jun 2018

    // John Carroll ENDPTS

    https://endpts.com/battered-gemphire-shares-soar-on-new-triglyceride-data-but-theres-a-lot-left-to-prove/

    John Carroll ENDPTS
    30 Jun 2018
    Share Share